| P50 | author | Satoshi Ōmura | Q21061207 |
| P2093 | author name string | Haruo Tanaka | |
| | Atsushi Takahashi | |
| | Shinichi Oka | |
| | Atsuko Hachiya | |
| | Junji Inokoshi | |
| P2860 | cites work | HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity | Q21076115 |
| | Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women | Q24629582 |
| | Crystal structures of the sugar complexes of Streptomyces olivaceoviridis E-86 xylanase: sugar binding structure of the family 13 carbohydrate binding module | Q27637656 |
| | Mechanism by which the lectin actinohivin blocks HIV infection of target cells | Q27657228 |
| | HIV entry and its inhibition | Q28273919 |
| | beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors | Q28294610 |
| | Proteins that bind high-mannose sugars of the HIV envelope | Q28295811 |
| | Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target | Q28369397 |
| | Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease | Q29616432 |
| | Structure of ricin B-chain at 2.5 A resolution. | Q30372288 |
| | Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120. | Q30909988 |
| | Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5) | Q33981401 |
| | Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy | Q34005185 |
| | Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein | Q34981730 |
| | Inhibition of HIV entry by carbohydrate-binding proteins | Q36434175 |
| | Microbicides: a new frontier in HIV prevention | Q36649988 |
| | Essential regions for antiviral activities of actinohivin, a sugar-binding anti-human immunodeficiency virus protein from an actinomycete | Q38327540 |
| | Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope | Q38343814 |
| | A simple screening system for anti-HIV drugs: syncytium formation assay using T-cell line tropic and macrophage tropic HIV env expressing cell lines--establishment and validation. | Q38943963 |
| | Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities | Q38943968 |
| | Glycosylation: heterogeneity and the 3D structure of proteins | Q40914186 |
| | Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry | Q41583314 |
| | Molecular cloning of actinohivin, a novel anti-HIV protein from an actinomycete, and its expression in Escherichia coli | Q42644711 |
| | Actinohivin: specific amino acid residues essential for anti-HIV activity | Q42907167 |
| | A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. | Q43691134 |
| | Structure and evolution of ricin B chain | Q47397814 |
| | β-Trefoil fold | Q56339973 |
| | Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV | Q81410989 |
| P433 | issue | 8 | |
| P304 | page(s) | 551-557 | |
| P577 | publication date | 2011-06-22 | |
| P1433 | published in | The Journal of Antibiotics | Q7743552 |
| P1476 | title | The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity | |
| P478 | volume | 64 | |